Annette North, EVP & General Counsel at Turning Point Therapeutics, Inc. (TPTX), sold 669 shares at $36.30 ($24K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Open-market sale of $24k TPTX by EVP & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TPTX | SELL | 2021-03-09 | $4.3M | — | Filing → |
| TPTX | SELL | 2021-02-02 | $5.7M | — | Filing → |